Estimating the prevalence of poor-quality anti-TB medicines: a neglected risk for global TB control and resistance
Objectives Tuberculosis (TB) remains a major global public health problem, especially with the recent emergence of multidrug-resistant TB and extensively drug-resistant TB. There has been little consideration of the extent of substandard and falsified (SF) TB medicines as drivers of resistance. We a...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-07-01
|
| Series: | BMJ Global Health |
| Online Access: | https://gh.bmj.com/content/8/7/e012039.full |